je.st
news
Maxim Group Cuts Cytori Therapeutics Price Target to $5.00
2015-08-09 03:47:14| Biotech - Topix.net
Separately, Roth Capital restated a "buy" rating and issued a $6.00 target price on shares of Cytori Therapeutics in a research note on Tuesday, June 16th. Shares of Cytori Therapeutics traded up 2.5122% during midday trading on Friday, reaching $0.4203.
Tags: price
group
target
cuts
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||